HeraMED Ltd.

hera-med.com

High-Tech Company
Public Company

(ASX: HMD)

TECH VERTICALS

Consumer, Diagnostics, Digital Health, FemTech, Healthtech, IoT, Life Sciences, MedTech

General Data

Sector	Digital Health
Company Stage:	Initial Revenues
Established	2011
Number of Employees	25
Employees in Israel	13
Reg. Number:	abCDe

DESCRIPTION

HeraMED is a technology startup developing a lineup of connected pregnancy monitoring products for home use. Harnessing state-of-the-art technology, HeraMED solutions are medically accurate, scientifically optimised, safe and affordable.

HeraMED vision is to revolutionise the pregnancy experience with technology that focuses on expectant mums. HeraMED set out to change the doctor-patient relationship from episodic and inconvenient to home-based and connected, giving way to continuous monitoring. In other words, better health care at a lower cost.

HeraMED is led by a team of medical professionals, engineers, product developers and marketing experts. With HeraMED solutions, HeraMED aim to dramatically change the pregnancy experience into one that is personalised and empathetic.

TECHNOLOGY

HeraMED’s HeraBEAT™ pregnancy monitor provides a comprehensive solution for daily tracking of vital measurements to indicate a fetus’s wellbeing, in the comfort of the expecting mom’s home. HeraBEAT™ incorporates an innovative and patent pending FHR (Fetal Heart Rate) sensor. Designed from the ground up to be used by the expecting mom, HeraBEAT™ integrates state of the art technology and medical grade accuracy with simple straightforward user interface and a distinctive design into a coherent, exclusive and affordable solution.

Products and Phases

Product	Phase
HeraBEAT	Approved CE Approved AMAR
HeraBEAT pregnancy monitor provides a comprehensive solution for daily tracking of vital measurements to indicate a fetus’s wellbeing. HeraBEAT incorporates an innovative and patent pending FHR (Fetal Heart Rate) sensor.

ESTIMATED ANNUAL SALES

	TARGET MARKETS
	Pregnant Women.

	BUSINESS MODEL
	B2C

SERVICE PROVIDERS

Company Name	Type
abC Defghij	Law Firm
abC Defghij	Accounting Firm

CONTACT INFO

Expand / Collapse All

Main Address: Netanya, Israel

Address	6 Meir Ariel St.,
POB	8576
City	Netanya
Country	Israel
Zip	4059300,

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

Branch Address: Sydney, NSW, Australia

Address	23-25 Hunter St.
City	Sydney, NSW
Country	Australia
Zip	2000

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

	MANAGEMENT

Key Executive

Name	Title
Ms. Anoushka Gungadin	CEO
Dr. Arturo Weschler	Chief Medical Officer
Mr. Moran Shochat	VP, R&D
Mr. Ariel Laden	VP, Product
Mr. Tal Slonim	Co-Founder
Mr. David Groberman	Co-Founder

	BOARD

Board

Member	Title	Affiliation
abC Defghij	Executive Chairman	Former CEO , Nanosonics
abC Defghij	Board Member	CEO & Co-Founder, HeraMed
abC Defghij	Board Member	COO & Co-Founder
abC Defghij	Board Member	CFO, Empired Limited

Public Offerings

Deal Date	Type of Offering	Exchange	Amount Raise	Valuation	Remarks
Dec. 11, 2018	IPO	ASX	abCDe	abCDe

	FINANCIAL ROUNDS

Total Capital Raised
abCDe

Financial Rounds

Numbers of Investors

Expand / Collapse All

Round

Date

Stage

Amount

Valuation

Seed - Extended

Mar. 13, 2018

Seed

abCDe

Seed

Dec. 10, 2017

Seed

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Investment Company	abCDe
abC Defghij	Traditional Industry	abCDe

	R&D Grants

Expand / Collapse All

Round

Date

Stage

Amount

Remarks

R&D Grant

Dec. 10, 2017

Seed

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij*	Government Agency	abCDe

R&D Grant

Jan. 01, 2014

R&D

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Government Agency	abCDe

R&D Grant

Jan. 01, 2011

Seed

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Government Agency	abCDe

Last Updated:	abCDe
IVC Number:	abCDe